Top Deal Highlights for Oct 2015:
- Glenmark in Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler® in Europe
- Lupin Limited and Germany based Boehringer Ingelheim announces a joint strategic alliance for co-marketing linagliptin in India
- Swedish Firm Recipharm acquires Majority Stake In India based Nitin Lifesciences for a consideration of about USD103 Mn
- C-CAMP, India inks pact with QB3 to build US-Indo Life Science Hub
- India based Cipla announces agreement to sell its entire 25% stake in Biomab Holding Limited, Hong Kong for a total consideration of USD 25,775,000
For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.
Aagami Updates:
- New Client Win: Herbal Extracts and Medicines Company appoints Aagami to develop its Strategy 2020 Plan Read more
- BIO Europe 2015, Munich, Germany - 35+ one to one partnering meetings scheudled for Aagami
- Aagami Expert Speak: Great opportunity for India based Global companies: Latin America on Sale: Time to Go Pharma Shopping! Read More